The "Refractory Metastatic Melanoma - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 4+ companies and 4+ ...
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Caribou Biosciences (CRBU – Research Report) today. The company’s ...
Reports revenue $10.1M, consensus $17.33M. “Reflecting on 2024, it was a year of strong execution leading to significant achievements for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback